PUBBLICAZIONI IN EXTENSO (Total Impact Factor 51.52)
BUCHSBAUM MS, HOLLANDER E, PALLANTI S, BALDINI ROSSI N, PLATHOLI J, NEWMARK R, BLOOM R, SOOD E. Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patients.
Neuropsychobiology. 2006; 53(3):157-68.
HOLLANDER E, PALLANTI S, BALDINI ROSSI N, SOOD E, BAKER BR, BUCHSBAUM MS.
Imaging monetary reward in pathological gamblers.
World J Biol Psychiatry. 2005; 6(2):113-120.
M M HAZNEDAR, F ROVERSI, S PALLANTI, N BALDINI ROSSI, D B SCHNUR, E M LICALZI, C TANG, P R HOF, E HOLLANDER, AND M S BUCHSBAUM. Fronto-Thalamo-Striatal Gray and White Matter Volumes and Anisotropy of Their Connections in Bipolar Spectrum Illnesses.
Biol Psychiatry. 2005; 57:733–742.
HOLLANDER E, PALLANTI S, ALLEN A, SOOD E, and BALDINI ROSSI N. Does Sustained-Release Lithium Reduce Impulsive Gambling and Affective Instability Versus Placebo in Pathological Gamblers With Bipolar Spectrum Disorders?
American Journal of Psychiatry. 2005, 162(1):137-145.
HOLLANDER E, SOOD E, BALDINI ROSSI N, BAKER B. Pharmacological Treatments of Pathological Gambling.
Journal of Gambling Studies. 2005, 21(1):99-108.
HOLLANDER E, BALDINI ROSSI N, SOOD E, PALLANTI S. Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo controlled study. International Journal of Neuropsychopharmacology. 2003 Dec; 6(4):397-401.
PINI S., AMADOR XF., DELL’OSSO L., BALDINI ROSSI N., CASSANO P., SAVINO M. and CASSANO GB. Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide.
International Clinical Psychopharmacology. 2003, 18:15-21.
GB CASSANO, N BALDINI ROSSI, S PINI. Psychopharmacology of Anxiety Disorders.
Dialogues in Clinical Neurosciences. 2002, Vol.4, No.3:271-285.
S. PALLANTI, N. BALDINI ROSSI, E. SOOD, E. HOLLANDER. Nefazodone treatment of pathological gambling: a prospective open label controlled trial.
Journal of Clinical Psychiatry. 2002; Vol.63, Num. 11:1034-1039.
S. PINI, M. C. HARDOY, N. BALDINI ROSSI, C. MASTROCINQUE, L. DELL’OSSO. Social Phobia: treatment approaches.
Psychiatric Networks. 2000; Vol. 3, Num. 1:27-46.
S. PINI, N. BALDINI ROSSI, D. BRAVI, P. DONDA. La fluoxetina nel trattamento del disturbo distimico.
Giornale Italiano di Psicopatologia. 2000; 6(1):165-173.
DE RONCHI, N. BALDINI ROSSI, G. VISCANTI, M.A. RAGGI, R. MICHETTI, D. GENTILE, F. BUGAMELLI, V. VOLTERRA. A one-year study with determination of levels of clozapine in plasma of treatment-refractory schizophrenic patients.
European Neuropsychopharmacology. 1998, 01(8).
G. BALDINI, N. BALDINI ROSSI, R. SCUBLA. Terapia elettroconvulsivante e sindrome maligna da neurolettici: due casi clinici.
Psychiatry On-Line-Italia. Volume 2, Issue 3, Paper 1.
TUGNOLI S., SCUBLA R., BALDINI ROSSI N. Correlazioni tra disturbo ossessivo-compulsivo e psicopatologia depressiva: revisione critica della letteratura.
Archivio di Psichiatria Generale. 1994 anno 4, fasc.1-3: 7-26.
LIBRI E CAPITOLI DI LIBRI
S PALLANTI, N BALDINI ROSSI, E HOLLANDER. Pathological Gambling. In: E Hollander & DJ Stein editors. CLINICAL MANUAL OF IMPULSE-CONTROL DISORDERS.
American Psychiatric Publishing, Inc.,Arlington VA, 2005.
A ROTONDO, N BALDINI ROSSI, GB CASSANO. I Disturbi del Controllo degli Impulsi Non Classificati Altrove. In: PSICOPATOLOGIA E CLINICA PSICHIATRICA. GB Cassano e A Tundo eds. UTET Editore, Torino, 2005.
S PINI, N BALDINI ROSSI, M MINIATI, GB CASSANO. Subthreshold mood disorders. In C. Faravelli, E Griez, DJ Nutt, J Zohar. MOOD DISORDERS: An Introduction to Clinical Management and Research.
John Wiley & Sons, Ltd, London 2004.
N BALDINI ROSSI (co-author) in: S Pallanti & LM Koran editors, LA CURA DEL PAZIENTE CON DISTURBO OSSESSIVO COMPULSIVO RESISTENTE.
Collana SINPF Progressi in Neuropsicofarmacologia, Airon Edizioni, Milano 2003.
CASSANO GB, BALDINI ROSSI N, PINI S. Comorbidity of depression and anxiety. In: S Kasper, JA den Boer and JMA Sitsen editors. HANDBOOK OF DEPRESSION AND ANXIETY – A Biological Approach: Second Edition, Revised and Expanded.
M. Dekker ed, New York 2003.
PALLANTI S, BALDINI ROSSI N, FRIEDBERG J, HOLLANDER E. Psychobiology of Impulse Control Disorders Not Otherwise Specified (NOS). In: D’haenen H, den Boer JA, and Willner P, eds. TEXTBOOK OF BIOLOGICAL PSYCHIATRY.
John Wiley & Sons, Ltd, London 2002.
PALLANTI S, BALDINI ROSSI N, HOLLANDER E. Terapia farmacologica del gioco d’azzardo patologico: stato dell’arte e nuove prospettive. In: Croce M, Zerbetto R, curatori, IL GIOCO & L'AZZARDO. IL FENOMENO, LA CLINICA, LE POSSIBILITÀ DI INTERVENTO.
Franco Angeli ed., 2002.
ACKNOLEDGEMENTS IN PAPERS
Grassi L, Rossi A, Barraco A, and Italian FINDER Study group. Factors Influencing Depression Endpoints Research (FINDER): Baseline results of Italian patients with depression. Annals of General Psychiatry 2009, 8:14.
Galderisi S, Maj M, Mucci A, Cassano GB, Invernizzi G, Rossi A, Vita A, Dell'Osso L, Daneluzzo E, Pini S. Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. American Journal of Psychiatry 2002 Jun;159(6):983-990.
Diana de Ronchi, Irma Faranca, Paola Forti, Giovanni Ravaglia, Marco Borderi, Roberto Manfredi, and Vittorio Volterra. Development of Acute Psychotic Disorders and Hiv-1 Infection. The International Journal of Psychiatry in Medicine 2000 Vol. 2, Num. 30: 173-183.
